“Sarcopenia- Pipeline Insights, 2015” -A DelveInsight’s Report

DWARKA, India - July 16, 2015 - PRLog -- DelveInsight, the leading market research and consulting company has added new report “Sarcopenia- Pipeline Insights, 2015” to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed.

The Sarcopenia- Pipeline Insights, 2015 report provides client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

·    R&D activities and technologies used along with the pipeline molecules in development.

·    Stages of development of pipeline molecules.

·  Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

·   Information related to collaborations, in-licensing and out-licensing deals.

The “Sarcopenia- Pipeline Insights” Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecules. Therefore, DelveInsight’s report on Sarcopenia helps to optimize portfolio by creating effective counter-strategies to gain competitive and therapeutic advantage in global Pharma market. In addition, it assesses the major market drivers and barriers in development of Pipeline molecules which helps to understand market for collaborations and licensing deals.

DelveInsight is offering the Report at a price of USD 1250 as a single user license, USD 2500 as a site license and USD 4000 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email at info@delveInsight.com